Lupin Pharmaceuticals Inc. recalls
Lupin Pharmaceuticals Inc. is named on 22 recalls in Recall Relay's records since November 2023, from FDA (26 recalled products: FDA lists each product as its own recall); the most recent was August 3, 2026.
All 26 recalled products, newest first.
-
Class IIofficial
Lupin Pharmaceuticals Inc. recalls Clobetasol Propionate Cream USPFailed content uniformity specifications.
-
Class IIofficial
Lupin Pharmaceuticals Inc. recalls Glucagon Emergency Kit for Low Blood SugarCGMP deviation: OOS result observed for the Gliding Force functionality test during 12-month long term stability testing.
-
Class IIofficial
Lupin Pharmaceuticals Inc. recalls prednisoLONE Acetate Ophthalmic SuspensionPresence of Foreign Substance
-
Class IIofficial
Lupin Pharmaceuticals Inc. recalls Liraglutide InjectionPresence of particulate matter: a white thread-like structure in the cartridge
-
Class IIofficial
Lupin Pharmaceuticals Inc. recalls Ganirelix Acetate InjectionFailed impurities/degradation specifications: out of specification results for Ganirelix acetate acrylic acid adduct impurity.
-
Class IIofficial
Lupin Pharmaceuticals Inc. recalls Sertraline Hydrochloride Tablets USPDefective container - seal not adhering to bottles
-
Class IIofficial
Lupin Pharmaceuticals Inc. recalls Amlodipine and Benazepril HCl Capsules USP 2.5 mg/10 mgLabeling: Incorrect or Missing Lot and/or Exp Date: released with wrong expiry date as Feb.2027 instead of Jan.2027
-
Class IIofficial
Lupin Pharmaceuticals Inc. recalls clomiPRAMINE Hydrochloride Capsules USP 25 mgFailed Impurities/Degradation Specifications: an out of specification result observed in degradation product test (any unspecified degradation product) during retention sample testing at expiry.
-
Class IIofficial
Lupin Pharmaceuticals Inc. recalls Lisinopril and Hydrochlorothiazide Tablets USP 20mg/12.5mgProduct Mix Up: This product is being recalled because of a complaint received that a sealed bottle of lisinopril and hydrochlorothiazide tablets 20mg/12.5 mg had a foreign tablet identified as atazanavir and ritonavir tablet 300mg/100mg.
-
Class IIofficial
Lupin Pharmaceuticals Inc. recalls clomiPRAMINE hydrochloride Capsules USPFailed Impurities/Degradation Specifications: an out of specification result observed in degradation product test (any unspecified degradation product) during 18-month long term stability study.
-
Class IIofficial
Lupin Pharmaceuticals Inc. recalls Levothyroxine Sodium TabletsFailed Impurities/Degradation Specifications: Out of specifications result observed in the drug substance for impurity test during 3-month long term stability study.
-
Class IIofficial
Lupin Pharmaceuticals Inc. recalls Ramipril Capsules USP 5 mgCGMP Deviations: Active pharmaceutical ingredient was sourced from an unapproved vendor
-
Class IIofficial
Lupin Pharmaceuticals Inc. recalls Ramipril Capsules USP 2.5 mgCGMP Deviations: Active pharmaceutical ingredient was sourced from an unapproved vendor
-
Class IIofficial
Lupin Pharmaceuticals Inc. recalls Ramipril Capsules USP 10 mgCGMP Deviations: Active pharmaceutical ingredient was sourced from an unapproved vendor
-
Class IIofficial
Lupin Pharmaceuticals Inc. recalls Cefixime for Oral Suspension USPSubpotent Drug- An out of specification ( OOS ) result observed in assay test during 18-month long term stability study.
-
Class IIofficial
Lupin Pharmaceuticals Inc. recalls Cefixime for Oral Suspension USP 200 mg/5 mL (50 mL Pack size)Failed Content Uniformity Specifications
-
Class IIofficial
Lupin Pharmaceuticals Inc. recalls Cefdinir for Oral Suspension USPDefective container: lack of seal integrity.
-
Class IIofficial
Lupin Pharmaceuticals Inc. recalls Cefdinir for Oral Suspension USP 125 mg/5 mL (60 mL when reconstituted)Presence of foreign substance: Product complaint of foreign material in reconstituted bottle.
-
Class IIofficial
Lupin Pharmaceuticals Inc. recalls Cefdinir for Oral Suspension USP 250 mg/5 mL (60 mL when reconstituted)Presence of foreign substance: Product complaint of foreign material in reconstituted bottle.
-
Class IIofficial
Lupin Pharmaceuticals Inc. recalls Rifampin Capsules USPSubpotent Drug
-
Class IIofficial
Lupin Pharmaceuticals Inc. recalls Voriconazole for Oral SuspensionLabeling: Incorrect or Missing Package Insert
-
Class IIofficial
Lupin Pharmaceuticals Inc. recalls Rifampin Capsules USP 300mgSubpotent Drug and Failed Impurities/Degradation Specifications
-
Class IIofficial
Lupin Pharmaceuticals Inc. recalls Rifampin Capsules USP 150mgSubpotent Drug and Failed Impurities/Degradation Specifications
-
Class IIofficial
Lupin Pharmaceuticals Inc. recalls Cefixime for Oral Suspension 100mg/5mLFailed Impurities/Degradation Specifications
-
Class IIofficial
Lupin Pharmaceuticals Inc. recalls Desloratadine Tablets USP 5mg a) 100 count (NDC 68180-153-01) and b) 500 count (NDC 68180-153-02) bottlesCGMP Deviations: N-Nitroso Desloratadine impurity result exceeded the acceptable intake limit.
-
Class IIofficial
Lupin Pharmaceuticals Inc. recalls Penicillamine Tablets USP 250 mgFailed Dissolution Specifications
This page groups recalls by the company name the agency printed, so it can include different companies with similar names, and a recall may name a store or distributor rather than the maker. It counts the recalls in Recall Relay's records, not a company's whole history; an FDA recall that lists several products counts once. Open a recall to see its details and the agency's official notice, which is always the final word. Recall Relay isn't affiliated with any agency or with the companies named here.
Severity labels say where they come from: “official” is the agency's own class, “advisory” is based on the agency's safety warning, and “est. risk” is Recall Relay's estimate from the hazard description, not an agency classification.
Hear about the next one
Recall Relay can email you when a new recall mentions Lupin Pharmaceuticals Inc. or any words you choose. Start with a free key (no card needed), then set up alerts on your account page.
Get recall alerts